AUDREY REEVES: Open Payments
NPI 1265279418 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 46 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $186 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $254 |
| Novo Nordisk Inc | 6 | $109 |
| Lilly USA, LLC | 5 | $93 |
| Astellas Pharma US Inc | 3 | $56 |
| Organon LLC | 1 | $51 |
| Abbott Laboratories | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $39 |
| Exact Sciences Corporation | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
Products named: VRAYLAR, UBRELVY, MOUNJARO, Veozah, NEXPLANON, FREESTYLE LIBRE 3, VOQUEZNA, NURTEC ODT.
Industry payments across LA — which companies pay providers there.
